Multiple sclerosis - natalizumab: Appendix B - proposal paper presented to the Institute's Guidance Executive
Multiple sclerosis - natalizumab: Appendix B - proposal paper presented to the Institute's Guidance Executive
02 May 2013 (749.78 Kb 38 sec) |
This page was last updated: 30 April 2013